NeuroOne Medical Technologies Corporation (NMTC)

NASDAQ: NMTC · Real-Time Price · USD
0.8800
-0.0091 (-1.02%)
At close: Sep 15, 2025, 4:00 PM EDT
0.8999
+0.0199 (2.26%)
After-hours: Sep 15, 2025, 7:57 PM EDT
-1.02%
Market Cap44.00M
Revenue (ttm)6.63M
Net Income (ttm)-5.34M
Shares Out 50.00M
EPS (ttm)-0.15
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume297,475
Open0.8901
Previous Close0.8891
Day's Range0.8777 - 0.9000
52-Week Range0.3954 - 1.3900
Beta0.72
AnalystsStrong Buy
Price Target2.23 (+153.41%)
Earnings DateAug 14, 2025

About NMTC

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, radio frequency and brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company also foc... [Read more]

Sector Healthcare
Founded 2009
Employees 17
Stock Exchange NASDAQ
Ticker Symbol NMTC
Full Company Profile

Financial Performance

In 2024, NMTC's revenue was $3.45 million, an increase of 1.33% compared to the previous year's $3.41 million. Losses were -$12.32 million, 3.87% more than in 2023.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for NMTC stock is "Strong Buy." The 12-month stock price target is $2.23, which is an increase of 153.41% from the latest price.

Price Target
$2.23
(153.41% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025

EDEN PRAIRIE, Minn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgic...

7 days ago - GlobeNewsWire

NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

FDA Clearance Further Validates Technology Platform and Offers Alternatives to Pharmaceutical and Invasive Surgical Treatments

4 weeks ago - GlobeNewsWire

NeuroOne Medical Technologies Corporation (NMTC) Q3 2025 Earnings Call Transcript

Protalix BioTherapeutics, Inc. (PLX) Q3 2025 Earnings Call August 14, 2025 8:30 AM ET Company Participants David A. Rosa - President, CEO & Director Ronald W.

4 weeks ago - Seeking Alpha

NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9%

Completed Oversubscribed $8.2 Million Capital Raise; Funded Through At Least Fiscal Year 2026 EDEN PRAIRIE, Minn., Aug. 14, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: ...

4 weeks ago - GlobeNewsWire

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update

EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgica...

6 weeks ago - GlobeNewsWire

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time

EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgica...

6 weeks ago - GlobeNewsWire

NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office

Patent Strengthens Intellectual Property Portfolio Surrounding Neural Probe Technologies EDEN PRAIRIE, Minn., July 23, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC)...

7 weeks ago - GlobeNewsWire

NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System

Patient Treated with OneRF ® Ablation System Previously Experienced up to 10 Seizures a Day EDEN PRAIRIE, Minn., June 23, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NM...

3 months ago - GlobeNewsWire

NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary

EDEN PRAIRIE, Minn., June 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgica...

3 months ago - GlobeNewsWire

NeuroOne to Attend MedInvest's MedTech, AI & Digital Health Conference on June 3-4, 2025

EDEN PRAIRIE, Minn., May 29, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical...

3 months ago - GlobeNewsWire

NeuroOne Medical Technologies Corporation (NMTC) Q2 2025 Earnings Call Transcript

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q2 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Dave Rosa – CEO Ron McClurg – CFO Chris Volker - COO Conference C...

4 months ago - Seeking Alpha

NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%

Filed 510(k)Submission with FDA for OneRF ® Trigeminal Nerve Ablation System to Treat Facial Pain Ahead of Schedule

4 months ago - GlobeNewsWire

NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor

Significant Neurological  Expertise to Help Drive Clinical Development Strategy and Growth with New Technologies

4 months ago - GlobeNewsWire

NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference

Eden Prairie, Minnesota--(Newsfile Corp. - May 5, 2025) - NeuroOne Medical (NASDAQ: NMTC), today announced its participation in the D. Boral Capital Inaugural Global Conference, taking place May 14, 2...

4 months ago - Newsfile Corp

NeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time

EDEN PRAIRIE, Minn., May 01, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical...

4 months ago - GlobeNewsWire

NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

Multi-Contact Probe Provides Alternative to Pharmaceutical and Invasive Surgical Treatments Submission Completed Earlier Than Anticipated EDEN PRAIRIE, Minn., April 23, 2025 (GLOBE NEWSWIRE) -- NeuroO...

5 months ago - GlobeNewsWire

NeuroOne® Issues Letter to Shareholders

Company Now Fully Funded Through at least Fiscal 2026; Company Confirms No Material Impact from Global Tariffs EDEN PRAIRIE, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Cor...

5 months ago - GlobeNewsWire

NeuroOne® OneRF® Technology Success Story Featured on Fox News

Pediatric Patient Treated with OneRF® Ablation System Goes From Up to 10 Nightly Seizures to Zero EDEN PRAIRIE, Minn., April 14, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nas...

5 months ago - GlobeNewsWire

Nasdaq Dips 5%; NeuroOne Medical Technologies Shares Plummet

U.S. stocks traded lower midway through trading, with the Dow Jones index dipping more than 1,100 points on Friday. Beijing unveiled a retaliatory 34% tariff on U.S. goods—mirroring the rate announced...

5 months ago - Benzinga

NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock

EDEN PRAIRIE, Minn., April 04, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care option...

5 months ago - GlobeNewsWire

NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock

EDEN PRAIRIE, Minn., April 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care option...

5 months ago - GlobeNewsWire

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace - Update

EDEN PRAIRIE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgic...

6 months ago - GlobeNewsWire

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace

EDEN PRAIRIE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgic...

6 months ago - GlobeNewsWire

NeuroOne CEO Joins Today's Marketplace To Discuss The Latest Treatments for Epilepsy

NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) --  Today's Marketplace (TMP) is proud to announce a featured interview with NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) CEO Dave Rosa and Jessic...

6 months ago - GlobeNewsWire

NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

Submission for New Intended Use That Leverages Company's Patented OneRF® Technology Platform Expected in May 2025  EDEN PRAIRIE, Minn., March 11, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies...

6 months ago - GlobeNewsWire